Cardinal Health (CAH) Stock Forecast & Price Target

$137.64 +1.80 (+1.33%)

Closing price 04/25/2025 03:59 PM Eastern

Extended Trading

$135.00 -2.64 (-1.92%)

As of 04/25/2025 07:26 PM Eastern

Cardinal Health - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy

Based on 14 Analyst Ratings

Sell
0

Hold
4

Buy
10

Based on 14 Wall Street analysts who have issued ratings for Cardinal Health in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 14 analysts, 4 have given a hold rating, and 10 have given a buy rating for CAH.

Consensus Price Target

$140.86
2.34% Upside

According to the 14 analysts' twelve-month price targets for Cardinal Health, the average price target is $140.86. The highest price target for CAH is $155.00, while the lowest price target for CAH is $124.00. The average price target represents a forecasted upside of 2.34% from the current price of $137.64.

Get the Latest News and Ratings for CAH and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Cardinal Health and its competitors.

CAH Analyst Ratings Over Time

Type	Current Forecast 4/26/24 to 4/26/25	1 Month Ago 3/27/24 to 3/27/25	3 Months Ago 1/27/24 to 1/26/25	1 Year Ago 4/27/23 to 4/26/24
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	10 Buy rating(s)	10 Buy rating(s)	11 Buy rating(s)	7 Buy rating(s)
Hold	4 Hold rating(s)	4 Hold rating(s)	4 Hold rating(s)	3 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	1 Sell rating(s)
Consensus Price Target	$140.86	$139.36	$134.64	$103.07
Forecasted Upside	2.34% Upside	1.79% Upside	4.47% Upside	-0.12% Downside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy

CAH Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

CAH Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Cardinal Health Stock vs. The Competition

Type	Cardinal Health	Medical Companies	S&P 500
Consensus Rating Score	2.71	2.82	2.54
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy
Predicted Upside	2.34% Upside	2,762.98% Upside	21.41% Upside
News Sentiment Rating	Positive News See Recent CAH News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
4/11/2025	Bank of America 3 of 5 stars	Michael Cherny Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Buy ➝ Buy	$150.00 ➝ $155.00	+20.16%
3/31/2025	Mizuho 3 of 5 stars	S. Valiquette Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Outperform ➝ Outperform	$142.00 ➝ $150.00	+9.95%
2/5/2025	Jefferies Financial Group 2 of 5 stars	Brian Tanquilut Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold ➝ Buy	$140.00 ➝ $150.00	+19.72%
2/4/2025	Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Kristina Ruggeri Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Target		$148.00	+16.57%
2/4/2025	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lisa Gill Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Neutral ➝ Neutral	$142.00 ➝ $145.00	+13.97%
2/4/2025	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	S. Baxter Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Equal Weight ➝ Equal Weight	$135.00 ➝ $136.00	+7.36%
1/31/2025	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Erin Wright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Overweight ➝ Overweight	$136.00 ➝ $142.00	+10.67%
1/10/2025	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Daniel Grosslight Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Neutral ➝ Neutral	$120.00 ➝ $129.00	+5.25%
1/8/2025	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating	C. Rhyee Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold ➝ Buy	$130.00 ➝ $144.00	+18.90%
1/7/2025	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating	E. Anderson Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	In-Line ➝ Outperform	$140.00 ➝ $140.00	+17.17%
Get the Latest News and Ratings for CAH and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Cardinal Health and its competitors with MarketBeat's FREE daily newsletter.
11/4/2024	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Hold ➝ Hold	$119.00 ➝ $124.00	+9.48%
11/4/2024	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$134.00 ➝ $139.00	+21.30%
11/4/2024	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$117.00 ➝ $133.00	+14.53%
8/15/2024	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$130.00 ➝ $137.00	+28.81%
2/26/2024	Leerink Partnrs Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Cherny Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform
2/26/2024	Leerink Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Outperform	$125.00	+15.64%
6/12/2023	Credit Suisse Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target		$90.00 ➝ $100.00	+15.82%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 03:06 AM ET.

Should I Buy Cardinal Health Stock? CAH Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Thursday, April 24, 2025. Please send any questions or comments about these Cardinal Health pros and cons to contact@marketbeat.com.

Cardinal Health
Bull Case

Here are some ways that investors could benefit from investing in Cardinal Health, Inc.:

The current stock price is around $131, reflecting a strong performance in the healthcare sector.
Recent upgrades from multiple analysts, including a "buy" rating and increased price targets, indicate positive market sentiment.
The company reported earnings per share (EPS) of $1.93, surpassing expectations, which suggests strong operational performance.
Cardinal Health, Inc. has a consistent dividend payout, with a recent quarterly dividend of $0.5056 per share, providing income to investors.
With a market capitalization of approximately $31.72 billion, Cardinal Health, Inc. is positioned as a significant player in the healthcare services and products industry.

Cardinal Health
Bear Case

Investors should be bearish about investing in Cardinal Health, Inc. for these reasons:

The company has a negative return on equity of 59.57%, indicating potential inefficiencies in generating profit from shareholders' equity.
Despite recent positive earnings, the net margin is only 0.59%, suggesting limited profitability relative to revenue.
Analysts have mixed ratings, with four holding a "hold" rating, which may indicate uncertainty about future performance.
The stock has experienced volatility, with a 1-year low of $93.17, which could concern risk-averse investors.
The payout ratio is currently at 37.69%, which, while manageable, may limit future dividend growth potential.

CAH Forecast - Frequently Asked Questions

: According to the research reports of 14 Wall Street equities research analysts, the average twelve-month stock price forecast for Cardinal Health is $140.86, with a high forecast of $155.00 and a low forecast of $124.00.
: 14 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Cardinal Health in the last twelve months. There are currently 4 hold ratings and 10 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" CAH shares.
: According to analysts, Cardinal Health's stock has a predicted upside of 2.34% based on their 12-month stock forecasts.
: Over the previous 90 days, Cardinal Health's stock had 1 upgrade by analysts.
: Cardinal Health has been rated by research analysts at Argus, Bank of America, Jefferies Financial Group, JPMorgan Chase & Co., Mizuho, Morgan Stanley, and Wells Fargo & Company in the past 90 days.
: Analysts like Cardinal Health less than other "medical" companies. The consensus rating score for Cardinal Health is 2.71 while the average consensus rating score for "medical" companies is 2.82. Learn more on how CAH compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top-Rated Stocks

More Ratings Tools

This page (NYSE:CAH) was last updated on 4/26/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Cardinal Health (CAH) Stock Forecast & Price Target